ACAD
Acadia Pharmaceuticals Inc
$25.77
-0.20 (-0.77%)
At close · Jul 6
Market Cap
$4.41B
Shares
171,235,870
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-29 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| 8-K | 2026-05-01 | 2026-04-27 | |
| DEF 14A | 2026-04-24 | 2026-05-29 | |
| 8-K | 2026-03-05 | 2026-03-03 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-25 | — | |
| 8-K | 2026-01-13 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 8-K | 2025-11-03 | 2025-10-28 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-10 | 2025-06-09 | |
| 8-K | 2025-05-29 | — | |
| 8-K | 2025-05-20 | 2025-05-15 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| DEF 14A | 2025-04-25 | 2025-05-29 | |
| 8-K | 2025-04-16 | 2025-04-15 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-26 | — | |
| 8-K | 2024-12-11 | — | |
| 8-K | 2024-11-20 | 2024-11-18 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-09-23 | 2024-09-17 | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-05-29 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-08 | — | |
| DEF 14A | 2024-04-26 | 2024-05-29 | |
| 8-K | 2024-03-11 | — | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-01-31 | 2024-01-30 | |
| 8-K | 2023-11-21 | — | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-08-02 | — | |
| 8-K | 2023-07-18 | 2023-07-13 | |
| 8-K | 2023-06-02 | 2023-06-01 | |
| 10-Q | 2023-05-08 | 2023-03-31 | |
| 8-K | 2023-05-08 | — | |
| DEF 14A | 2023-05-01 | 0001-01-01 | |
| 8-K | 2023-03-13 | 2023-03-10 | |
| 8-K | 2023-02-28 | 2023-02-27 |
Showing 1–50 of 97 filings